GENE ONLINE|News &
Opinion
Blog

Astellas Pharma
Partnerships JapanJoint Venture Partner Group
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
Interviews BioJapanJapan
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Sept 4-Sept 8
2023-09-12
Asia-Pacific Lawsuit
Astellas Withdraws Lawsuit Against IRA but Maintains Concerns
2023-09-11
Licensing Astellas PharmaGene Therapy
Astellas Secures Licensing Agreement with 4D Molecular Therapeutics for Gene Therapy Vector Technology
2023-07-12
Trials & Approvals Astellas PharmaFezolinetant
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
M&A Astellas Pharma
Astellas Trains Sights On Iveric Bio In $5.9 Billion Acquisition
2023-05-03
Trials & Approvals Xtandi
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Trials & Approvals Phase 3 Trial
Astellas Clears Primary Endpoints In Prostate Cancer And Menopause Trials
2023-03-14
Special JPM
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
Trials & Approvals Astellas Pharma
Astellas’ Zolbetuximab Meets Phase 3 Endpoints In Gastric And GEJ Cancers
2022-12-16
Trials & Approvals Astellas Pharma
Astellas’ Claudin 18.2 Antibody Shows Its Teeth In GEJ Cancer Trial
2022-11-17
Asia-Pacific Astellas Pharma
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
Trials & Approvals Astellas Pharma
EMA Begins Regulatory Review For Astellas’ Fezolinetant
2022-10-03
1 2 3
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
READ MORE
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top